Drilldown: Medicines
Appearance
Medicines > onset
:
30-60 minutes
or
Estrogen suppression within days; clinical effect over months
& duration:
24 hours 
:
30-60 minutes
or
Estrogen suppression within days; clinical effect over months
& duration:
24 hours 
Use the filters below to narrow your results.
[[:Category:Antihistamines|Antihistamine]] (2) ·
[[:Category:Antineoplastics|Antineoplastic]] (1) ·
[[:Category:Aromatase_inhibitors|Aromatase inhibitor (non-steroidal)]] (1) ·
[[:Category:Endocrine_therapy|Endocrine therapy]] (1) ·
[[:Category:H1_receptor_antagonists|Histamine H1 receptor antagonist (second-generation)]] (2)
None (1) ·
'"`UNIQ--vote-00000391-QINU`"' Minimal CYP metabolism; mostly renally cleared unchanged. Cetirizine is the active racemate; levocetirizine is the active R-enantiomer marketed separately'"`UNIQ--ref-00000392-QINU`"'. (1) ·
'"`UNIQ--vote-00000950-QINU`"' Mostly renally cleared unchanged; dose-reduce in renal impairment. Like cetirizine, retains slightly more sedation than fexofenadine in some users'"`UNIQ--ref-00000951-QINU`"'. (1)
Contraindicated in pregnancy (only used in postmenopausal women); D class historically.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Generally considered safe; widely used. Cetirizine and loratadine remain the more-studied alternatives.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Generally considered safe; widely used. Levocetirizine (the R-enantiomer) is an alternative with similar safety.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 3 results in range #1 to #3.

